MICHAEL COLOTTA: Open Payments
NPI 1477824340 · HENDERSON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,242 in 131 payments from 20 companies in 2025. Trend: 2023 $1,749 · 2024 $1,791 · 2025 $2,242
Food & beverage: $2,242
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 12 | $493 |
| ABBVIE INC. | 27 | $319 |
| Novo Nordisk Inc | 20 | $311 |
| Lilly USA, LLC | 15 | $210 |
| Bayer Healthcare Pharmaceuticals Inc. | 15 | $209 |
| Amgen Inc. | 16 | $179 |
| PFIZER INC. | 4 | $75 |
| GlaxoSmithKline, LLC. | 5 | $75 |
| Otsuka America Pharmaceutical, Inc. | 2 | $58 |
| Abbott Laboratories | 3 | $57 |
Products named: AIRSUPRA, Kerendia, MOUNJARO, Wegovy, VRAYLAR, BREZTRI, FARXIGA, REXULTI.
Industry payments across TX — which companies pay providers there.
